<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Chapter 03 Medical Laboratories — Licenses | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.10.03/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.10.03/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|10|03|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="doc-num" content="03"/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|10|03" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/10.10.03"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Chapter 03 Medical Laboratories — Licenses | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.10.03/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.10.03/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10.10" title="Subtitle 10 LABORATORIES">Subtitle 10 LABORATORIES</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|10|03" data-search-heading="">
                  <span title="Chapter 03 Medical Laboratories — Licenses">Chapter 03 Medical Laboratories — Licenses</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|10|03">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.10.03">Chapter 03 Medical Laboratories — Licenses</h1>
                <section class="line-group annotations">
                  <h2>Administrative History</h2>
                  <p>Effective date: December 13, 1999 (26:25 Md. R. 1897)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.01" title=".01 General.">Regulation .01</a> amended effective July 24, 2000 (27:14 Md. R. 1340); July 23, 2001 (28:14 Md. R. 1321)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.01#A" title="">Regulation .01A</a> amended effective June 1, 2009 (36:11 Md. R. 787)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.01#E" title="">Regulation .01E</a> adopted effective June 1, 2009 (36:11 Md. R. 787)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.02" title=".02 Letters of Exception.">Regulation .02</a> amended effective July 24, 2000 (27:14 Md. R. 1340); June 1, 2009 (36:11 Md. R. 787); April 13, 2015 (42:7 Md. R. 568)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.02#A" title="">Regulation .02A</a> amended effective July 22, 2002 (29:14 Md. R. 1074); April 16, 2012 (39:7 Md. R. 492)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.02#B" title="">Regulation .02B</a> amended as an emergency provision effective November 1, 2004 (31:25 Md. R. 1789); amended permanently effective January 6, 2005 (31:26 Md. R. 1863)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.02#B" title="">Regulation .02B</a> amended effective August 29, 2005 (32:17 Md. R. 1438); February 22, 2010 (37:4 Md. R. 341); April 16, 2012 (39:7 Md. R. 492); November 12, 2012 (39:22 Md. R. 1428); April 1, 2013 (40:6 Md. R. 473); March 13, 2017 (44:5 Md. R. 292)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.02#C" title="">Regulation .02C</a> amended effective November 12, 2012 (39:22 Md. R. 1428)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.03#C" title="">Regulation .03C</a> amended effective June 1, 2009 (36:11 Md. R. 787); August 29, 2016 (43:17 Md. R. 953)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.04" title=".04 Letter of Exception and Permit — Administrative Procedures.">Regulation .04</a> amended effective June 1, 2009 (36:11 Md. R. 787)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.04#B" title="">Regulation .04B</a>, E amended effective August 29, 2016 (43:17 Md. R. 953)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.05" title=".05 Letter of Exception — Limited Testing for Rare Diseases.">Regulation .05</a> adopted effective June 1, 2009 (36:11 Md. R. 787)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.06" title=".06 Letter of Exception — Limited Testing for Rare Diseases; Standards and Requirements.">Regulation .06</a> adopted effective June 1, 2009 (36:11 Md. R. 787)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.03.06#A" title="">Regulation .06A</a> amended effective August 29, 2016 (43:17 Md. R. 953)</p>
                  <h2>Authority</h2>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gen&amp;section=6-303" title="">Environment Article, §6-303</a>; Health-General Article, §§2-104(b), 17-202, 17-205—17-210, 17-212, 17-502, 17-503, 17-505, <br/>17-508, and 17-510; Annotated Code of Maryland</p>
                </section>
                <h2 id="/us/md/exec/comar/10.10.03.01" data-order="|10|10|03|.01|" data-ref-path="10|10|03|.01" class="h__section">.01 General.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#A">A.</span> Requirement.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#A(1)">(1)</span> General. A person shall possess a license before:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#A(1)(a)">(a)</span> Offering to perform or performing a medical laboratory test or examination in this State;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#A(1)(b)">(b)</span> Offering to perform or performing a medical laboratory test or examination on a specimen acquired from a health care provider in this State at a laboratory located outside this State; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#A(1)(c)">(c)</span> Representing or servicing in this State a laboratory regardless of the laboratory's location.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#A(2)">(2)</span> Prohibited Tests. The Secretary may impose principal and alternative sanctions as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.08.01#A" title="">COMAR 10.10.08.01A</a> if a person offers to perform or performs a test or part of a test, including the use of a reagent, supply, procedure, technique, kit, or equipment, that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#A(2)(a)">(a)</span> Does not produce accurate or reliable results as evidenced by documented, independent scientific testing and evaluation; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#A(2)(b)">(b)</span> Lacks proof of efficacy substantiated by an independently conducted and documented scientifically based clinical trial.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#A(3)">(3)</span> Cholesterol Testing Plan for Health Departments.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#A(3)(a)">(a)</span> A local or county health department intending to perform cholesterol testing outside a permanently located laboratory may submit to the Secretary a cholesterol testing plan instead of applying for a cholesterol testing permit.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#A(3)(b)">(b)</span> If the submitted plan meets applicable standards under this chapter, the Secretary may waive the permit requirement for a cholesterol testing permit.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#A(3)(c)">(c)</span> If the plan does not meet the applicable standards of this chapter, the local or county health department shall apply for a permit as set forth in this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#B">B.</span> Limitation. A person may not operate a laboratory in a discipline other than what is listed on the license.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#C">C.</span> Eligibility. A person meeting the requirements and standards of this chapter may apply for one or more of the following licenses:</p>
                <div class="table_wrap">
                  <table class="layout-table">
                    <tbody>
                      <tr>
                        <td>License:</td>
                        <td>Laboratory that may apply for the license:</td>
                      </tr>
                      <tr>
                        <td>Letter of exception</td>
                        <td>POL<br/>POCL</td>
                      </tr>
                      <tr>
                        <td>Permit (single-site)</td>
                        <td>POL<br/>POCL<br/>State, county, or municipal hospital<br/>commercial</td>
                      </tr>
                      <tr>
                        <td>Permit (multi-site)</td>
                        <td>State, county, or municipal hospital<br/>private nonprofit<br/>mobile</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#D">D.</span> Issuance.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#D(1)">(1)</span> Provisional Permit.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#D(1)(a)">(a)</span> The Secretary may issue a provisional permit before or after conducting an initial survey and pending determination of compliance with the standards in this chapter.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#D(1)(b)">(b)</span> A provisional permit is valid for not more than 180 days and may not be renewed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#D(2)">(2)</span> Letter of Exception and Permit. The Secretary may issue a letter of exception or permit that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#D(2)(a)">(a)</span> Is valid for not more than 2 years from the date of issue; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#D(2)(b)">(b)</span> Shall be renewed before its date of expiration if a person intends to operate the laboratory in the succeeding permit period.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#D(3)">(3)</span> Single-Site and Multi-Site Licenses.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#D(3)(a)">(a)</span> Except as set forth in <a class="internal-link " href="/us/md/exec/comar/10.10.03.01#D(3)(b)" title="">§D(3)(b) of this regulation</a>, a person shall obtain a separate, single-site license for each location at which a laboratory performs a test.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#D(3)(b)">(b)</span> The Secretary may issue a multi-site license to a person operating:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#D(3)(b)(i)">(i)</span> A mobile laboratory using the address of its home base or main administrative office in the State;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#D(3)(b)(ii)">(ii)</span> A nonprofit laboratory or public health laboratory performing limited public health testing; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#D(3)(b)(iii)">(iii)</span> Hospital laboratories located at the same street address or within contiguous buildings and under common direction.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.01#E">E.</span> In order to maintain a State license issued by the Department pursuant to this subtitle, a licensee shall be in compliance with all applicable federal, State, and local laboratory requirements.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.10.03.02" data-order="|10|10|03|.02|" data-ref-path="10|10|03|.02" class="h__section">.02 Letters of Exception.</h2>
                <div class="message message--info" role="region" tabindex="0" aria-label="Warning">
                  <div class="h__message">Pending Changes</div>
                  <p>This section will be changed by the following pending documents:</p>
                  <ul>
                    <li>March 1, 2026: <a href="/us/md/exec/register/52/24">Maryland Register, Volume 52, Issue 24</a></li>
                  </ul>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A">A.</span> Eligibility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(1)">(1)</span> An individual directing a POL or POCL who offers to perform or performs tests limited to one or more excepted tests may obtain a letter of exception instead of a permit to offer to perform or perform those tests.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)">(2)</span> An individual eligible for a letter of exception shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)(a)">(a)</span> Be qualified as a laboratory director as set forth in 42 CFR §493.1405, including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)(a)(i)">(i)</span> Being a doctor of medicine or doctor of osteopathy licensed in the State and having laboratory training or experience appropriate for the testing performed; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)(a)(ii)">(ii)</span> Holding an earned doctoral, master's, or bachelor's degree in a chemical, physical, biological, or clinical laboratory science or medical technology from an accredited institution;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)(b)">(b)</span> Provide evidence of training in the performance and interpretation of excepted tests and be licensed in the State as a:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)(b)(i)">(i)</span> Nurse midwife;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)(b)(ii)">(ii)</span> Nurse practitioner;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)(b)(iii)">(iii)</span> Physician assistant;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)(b)(iv)">(iv)</span> Chiropractor;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)(b)(v)">(v)</span> Podiatrist;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)(b)(vi)">(vi)</span> Dentist; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)(b)(vii)">(vii)</span> Pharmacist; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)(c)">(c)</span> Be clinical staff who:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)(c)(i)">(i)</span> Meets the qualifications set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.01.06#D" title="">COMAR 10.47.01.06D</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)(c)(ii)">(ii)</span> Is employed by a substance abuse treatment program that is certified or accredited in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.47.04.03" title=".03 Certification Required.">COMAR 10.47.04.03</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(2)(c)(iii)">(iii)</span> Is authorized to order tests to detect the presence of controlled dangerous substances on patients enrolled in the substance abuse treatment program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#A(3)">(3)</span> A person operating a temporary medical laboratory to perform health awareness tests, regardless of testing site location, is not eligible for a letter of exception.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B">B.</span> Excepted Tests. A POL or POCL operating under a letter of exception may perform one or more of the following excepted tests or types of tests:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(1)">(1)</span> Whole blood glucose by glucose monitoring devices cleared by the FDA for home use or a CLIA waived analyzer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(2)">(2)</span> Dermatophyte screen;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(3)">(3)</span> Dipstick glucose;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(4)">(4)</span> Dipstick urinalysis using reagent test pads affixed to plastic strips that detect one or a combination of any of the following urine characteristics or constituents:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(4)(a)">(a)</span> Glucose;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(4)(b)">(b)</span> Bilirubin;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(4)(c)">(c)</span> Ketones detected in the form of acetoacetic acid;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(4)(d)">(d)</span> Specific gravity;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(4)(e)">(e)</span> Red blood cells or hemoglobin;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(4)(f)">(f)</span> pH;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(4)(g)">(g)</span> Protein;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(4)(h)">(h)</span> Urobilinogen;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(4)(i)">(i)</span> Nitrites; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(4)(j)">(j)</span> Leukocytes;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(5)">(5)</span> Gram stain;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(6)">(6)</span> Group A streptococcal screen;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(7)">(7)</span> Hematocrit;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(8)">(8)</span> Hemoglobin;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(9)">(9)</span> Infectious mononucleosis slide or card test;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(10)">(10)</span> Microscopic urinalysis;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(11)">(11)</span> Occult blood;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(12)">(12)</span> Pinworms;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(13)">(13)</span> Potassium hydroxide skin preparations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(14)">(14)</span> Rheumatoid factor slide agglutination test;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(15)">(15)</span> Sickle-cell screen;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(16)">(16)</span> H. pylori test with a single-use test device for nonforensic testing, using a whole-blood specimen;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(17)">(17)</span> Fructosamine test with a single-use test device for nonforensic testing, using a whole-blood specimen;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(18)">(18)</span> Heterophile antibodies test with a single-use test device for nonforensic testing, using a whole-blood specimen;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(19)">(19)</span> Urine bacteria colony count;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(20)">(20)</span> Urine pregnancy test;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(21)">(21)</span> Wet mounts;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(22)">(22)</span> Influenza antigen test using a direct nasal or throat swab specimen;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(23)">(23)</span> Hemoglobin A1c test using a whole blood specimen;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(24)">(24)</span> Qualitative test for bladder cancer markers in voided urine including a test to detect:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(24)(a)">(a)</span> Human complement factor H-related protein; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(24)(b)">(b)</span> Nuclear mitotic apparatus protein (NMP);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(25)">(25)</span> Brain natriuretic peptide (BNP) test using a whole blood specimen to detect:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(25)(a)">(a)</span> Heart disease; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(25)(b)">(b)</span> The response of treatment for heart failure;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(26)">(26)</span> Fern test for qualitative detection of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(26)(a)">(a)</span> Amniotic fluid crystallization; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(26)(b)">(b)</span> Estrogenic activity;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(27)">(27)</span> Qualitative semen analysis, limited to detecting:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(27)(a)">(a)</span> The presence or absence of sperm; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(27)(b)">(b)</span> Sperm motility;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(28)">(28)</span> Nitrazine vaginal pH test using phenaphthazine reagent paper strips;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(29)">(29)</span> Qualitative immunochromatographic test to detect the presence of adenovirus antigens directly from eye fluid;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(30)">(30)</span> Microalbumin-creatinine urinalysis test utilizing an instrument based dip-and-read reagent test strip for determining urine albumin and creatinine levels, including the urinary albumin-to-creatinine ratio (UACR) in a random urine specimen;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(31)">(31)</span> Screening tests for urine or saliva performed on FDA-cleared for home use or FDA approved single-use test devices for the presence of alcohol and drugs of abuse solely for the purpose of directing patient counseling;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(32)">(32)</span> Qualitative enzyme activity test using a chromogenic substrate of bacterial sialidase for use in the detection of bacterial vaginosis directly from vaginal fluid specimens;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(33)">(33)</span> Qualitative immunochromatographic test to detect the presence of Trichomonas vaginalis antigens directly from a vaginal swab;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(34)">(34)</span> CLIA-waived Prothrombin Time/International Normalized Ratio (PT/INR) with the additional requirements that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(34)(a)">(a)</span> The licensee shall enroll into a Proficiency Testing program offered by an entity that has been approved by the Centers for Medicare and Medicaid Services (CMS) to ensure validation of all measurement capabilities for the instrument used to perform the test; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(34)(b)">(b)</span> When the numerical score is less than 80 percent, the licensee shall submit the official proficiency test results to the Office of Health Care Quality for review and monitoring with evidence of documented remedial actions taken;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(35)">(35)</span> CLIA waived blood lipid analysis for cholesterol, HDL, LDL, and triglycerides;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(36)">(36)</span> Whole blood lead testing on a CLIA waived analyzer with the additional requirements:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(36)(a)">(a)</span> The licensee shall enroll into a Proficiency Testing program offered by an entity that has been approved by the Centers for Medicare and Medicaid Services to ensure validation of all measurement capabilities for the instrument used to perform the test;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(36)(b)">(b)</span> When the numerical score is less than 80 percent, the licensee shall submit the official proficiency test result to the Office of Health Care Quality for review and monitoring with evidence of documented remedial actions taken;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(36)(c)">(c)</span> All staff involved in testing shall undergo training on the testing device and testing techniques with annual competencies;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(36)(d)">(d)</span> Records of training and competencies for staff shall be:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(36)(d)(i)">(i)</span> Maintained by the laboratory; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(36)(d)(ii)">(ii)</span> Made available for review by the Department; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(36)(e)">(e)</span> Reporting requirements stated in <a class="internal-link " href="/us/md/exec/comar/10.10.03.02#C" title="">§C of this regulation</a> shall be followed; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(37)">(37)</span> CLIA Waived Urine Drug Screens with the following additional requirements:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(37)(a)">(a)</span> The licensee shall enroll into a proficiency testing program offered by an entity that has been approved by the Centers for Medicare and Medicaid Services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#B(37)(b)">(b)</span> When the numerical score is less than 80 percent, the licensee shall submit the official proficiency test result to the Office of Health Care Quality for review and monitoring with evidence of documented remedial actions taken.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C">C.</span> Reporting Requirements for Whole Blood Lead Testing on a CLIA Waived Analyzer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(1)">(1)</span> The blood tests for lead shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(1)(a)">(a)</span> Be reported under this regulation in the format approved by the Maryland Department of the Environment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(1)(b)">(b)</span> Include the information required by this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(2)">(2)</span> The blood tests for lead to be reported shall include the following information:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(2)(a)">(a)</span> Demographic information including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(2)(a)(i)">(i)</span> Name, including first, last, middle initial;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(2)(a)(ii)">(ii)</span> Date of birth, sex, and race;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(2)(a)(iii)">(iii)</span> Complete home address at the time the blood specimen was drawn including house or apartment number, street, city, county or town, zip code, and state;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(2)(a)(iv)">(iv)</span> Telephone number; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(2)(a)(v)">(v)</span> Parent or guardian name;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(2)(a)(vi)">(vi)</span> Residential status, for example, whether parent or guardian owns their home or rents;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(2)(b)">(b)</span> Type of specimen, either venous or capillary, and date the specimen was drawn;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(2)(c)">(c)</span> Clinic or practice name, address, and telephone number;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(2)(d)">(d)</span> Draw site name and address, if different from clinic or practice;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(2)(e)">(e)</span> Blood lead level in micrograms per deciliter; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#C(2)(f)">(f)</span> Any additional information as may be required by the Maryland Department of the Environment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#D">D.</span> Regulatory Requirements. An individual required to obtain a license to operate a laboratory who chooses to operate under a letter of exception shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#D(1)">(1)</span> Obtain, complete, and file an application as prescribed in <a class="internal-link " href="/us/md/exec/comar/10.10.03.04" title=".04 Letter of Exception and Permit — Administrative Procedures.">Regulation .04 of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#D(2)">(2)</span> Comply with good laboratory practices that include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#D(2)(a)">(a)</span> Following the manufacturer's instructions for instrument or test system operation and test performance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#D(2)(b)">(b)</span> Having a procedure manual describing the processes for performing tests and reporting patient test results;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#D(2)(c)">(c)</span> Performing and documenting quality control procedures using applicable levels of control materials each day of testing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#D(2)(d)">(d)</span> Performing and documenting that remedial action has been taken when problems or errors are identified;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#D(2)(e)">(e)</span> Documenting lot numbers of all quality control reagents used; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.02#D(2)(f)">(f)</span> Performing and documenting test system function for instruments with internal quality controls on each day of testing.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.10.03.03" data-order="|10|10|03|.03|" data-ref-path="10|10|03|.03" class="h__section">.03 Permits.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.03#A">A.</span> Requirement. A person operating a medical laboratory that performs one or more tests other than excepted tests shall obtain and renew a laboratory permit as required in this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.03#B">B.</span> Tests Other than Excepted Tests.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.03#B(1)">(1)</span> A test other than an excepted test is one not listed in <a class="internal-link " href="/us/md/exec/comar/10.10.03.02#B" title="">Regulation .02B of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.03#B(2)">(2)</span> A person holding a permit may perform both excepted tests and tests other than excepted tests.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.03#C">C.</span> Regulatory Requirements. A person operating a medical laboratory under a permit shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.03#C(1)">(1)</span> Obtain, complete, and submit permit applications as prescribed in this chapter and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.04" title="Chapter 04 Medical Laboratories">COMAR 10.10.04</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.03#C(2)">(2)</span> Comply with the survey requirements set forth in this subtitle;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.03#C(3)">(3)</span> Comply with the applicable quality assurance and quality control requirements required in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.06" title="Chapter 06 Medical Laboratories — Quality Assurance">COMAR 10.10.06</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.03#C(4)">(4)</span> Comply with the applicable proficiency testing requirements required in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.05" title="Chapter 05 Medical Laboratories — Proficiency Testing">COMAR 10.10.05</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.03#C(5)">(5)</span> Comply with the applicable personnel requirements required in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.06.15#B" title="">COMAR 10.10.06.15B</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.07" title="Chapter 07 Medical Laboratories — Personnel">10.10.07</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.10.03.04" data-order="|10|10|03|.04|" data-ref-path="10|10|03|.04" class="h__section">.04 Letter of Exception and Permit — Administrative Procedures.</h2>
                <div class="message message--info" role="region" tabindex="0" aria-label="Warning">
                  <div class="h__message">Pending Changes</div>
                  <p>This section will be changed by the following pending documents:</p>
                  <ul>
                    <li>March 1, 2026: <a href="/us/md/exec/register/52/24">Maryland Register, Volume 52, Issue 24</a></li>
                  </ul>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#A">A.</span> Application — Filing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#A(1)">(1)</span> Except for a laboratory eligible for a multi-site license as set forth in <a class="internal-link " href="/us/md/exec/comar/10.10.03.01#D(3)(b)" title="">Regulation .01D(3)(b) of this chapter</a>, a person shall apply for a license for each laboratory location.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#A(2)">(2)</span> A person holding a license to operate a laboratory in the discipline of chemistry or health awareness testing is not required to obtain a separate cholesterol testing permit to conduct cholesterol testing at a temporary laboratory site if the licensee complies with the requirements applicable to a temporary laboratory as set forth in this subtitle.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#A(3)">(3)</span> A person shall complete and file an application for a license using forms provided by the OHCQ.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#A(4)">(4)</span> A person shall complete on the application a description of laboratory services, which includes but is not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#A(4)(a)">(a)</span> Types of tests performed or to be performed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#A(4)(b)">(b)</span> Total number of tests performed or to be performed annually, excluding tests for quality control and proficiency testing; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#A(4)(c)">(c)</span> Qualifications of personnel who direct, supervise, and perform laboratory testing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#A(5)">(5)</span> The laboratory director shall sign the application forms attesting that the information provided is accurate and that the laboratory is or will be operated in accordance with the requirements and standards required in this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#A(6)">(6)</span> A person shall submit with the application the nonrefundable partial licensing fee set forth in COMAR 10.10.04.02C.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#B">B.</span> Application — Evaluation and Billing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#B(1)">(1)</span> The OHCQ shall review and evaluate an application in accordance with the standards and requirements of this subtitle to determine if an application is complete.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#B(2)">(2)</span> The OHCQ shall review and evaluate an application in accordance with the standards and requirements of this subtitle to determine if the laboratory is eligible for a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#B(2)(a)">(a)</span> Letter of exception;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#B(2)(b)">(b)</span> Letter of exception — limited testing for rare diseases; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#B(2)(c)">(c)</span> Permit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#C">C.</span> Application — Denial of License. If the OHCQ determines that a laboratory is not in compliance with the requirements of this chapter and therefore cannot be issued a license, the OHCQ shall provide to the laboratory:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#C(1)">(1)</span> A written statement of the grounds on which the denial is based; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#C(2)">(2)</span> The opportunity to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#C(2)(a)">(a)</span> Amend and resubmit the application; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#C(2)(b)">(b)</span> Request, in writing, an opportunity for a hearing as provided in the Administrative Procedure Act, State Government Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-201" title="">10-201</a>—<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-226" title="">10-226</a>, and Health-General Article, §§17-210 and 17-509, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#D">D.</span> Notification Requirements. A licensee shall notify the OHCQ within 30 days of a change in laboratory:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#D(1)">(1)</span> Ownership;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#D(2)">(2)</span> Name;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#D(3)">(3)</span> Location; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#D(4)">(4)</span> Director.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#E">E.</span> Amending a Permit. Except as prescribed in <a class="internal-link " href="/us/md/exec/comar/10.10.03.04#D" title="">§D of this regulation</a>, a licensee holding an unexpired permit who wishes to amend it shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#E(1)">(1)</span> Submit a written request for amendment to the Secretary; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#E(2)">(2)</span> Obtain written approval from the OHCQ before implementing the amendment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#F">F.</span> Expiration and Renewal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#F(1)">(1)</span> A letter of exception or permit expires on the date shown on the license.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#F(2)">(2)</span> The OHCQ shall mail a renewal application to a laboratory not less than 30 days before the expiration date shown on the license.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#F(3)">(3)</span> A licensee shall file an application to renew a license using forms provided by the OHCQ and following the same procedures prescribed in §§A and B of this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#F(4)">(4)</span> A licensee who fails to submit a completed renewal application before the expiration date may not operate the laboratory after its letter of exception or permit has expired.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.04#G">G.</span> Non-Transferability. A license is not transferable between laboratories, directors, or locations.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.10.03.05" data-order="|10|10|03|.05|" data-ref-path="10|10|03|.05" class="h__section">.05 Letter of Exception — Limited Testing for Rare Diseases.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.05#A">A.</span> The Secretary may waive the permit requirements under this subtitle for a laboratory that offers to perform or performs a rare disease test if the laboratory:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.05#A(1)">(1)</span> Meets the requirements of Regulations .05 and .06 of this chapter; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.05#A(2)">(2)</span> Obtains and maintains a letter of exception — limited testing for rare diseases.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.05#B">B.</span> Eligibility. A person operating a medical laboratory may be eligible for a letter of exception — limited testing for rare diseases if the laboratory:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.05#B(1)">(1)</span> Is operated as:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.05#B(1)(a)">(a)</span> A not-for-profit entity; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.05#B(1)(b)">(b)</span> Part of an accredited educational institution;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.05#B(2)">(2)</span> Performs not more than a total of 50 tests per year for a specific rare disease on specimens from Maryland patients;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.05#B(3)">(3)</span> Offers to perform or performs only rare disease tests as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.01.03#B" title="">COMAR 10.10.01.03B</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.05#B(4)">(4)</span> Possesses a valid CLIA certificate for the complexity of the testing performed;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.05#B(5)">(5)</span> Does not possess a Maryland permit for offering to perform or performing medical laboratory testing; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.05#B(6)">(6)</span> Meets the requirements for a laboratory to operate under a letter of exception — limited testing for rare diseases.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.05#C">C.</span> Research Laboratory. A research laboratory may obtain a letter of exception — limited testing for rare diseases if the laboratory meets the eligibility requirements of <a class="internal-link " href="/us/md/exec/comar/10.10.03.05#B" title="">§B of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.10.03.06" data-order="|10|10|03|.06|" data-ref-path="10|10|03|.06" class="h__section">.06 Letter of Exception — Limited Testing for Rare Diseases; Standards and Requirements.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A">A.</span> Application Requirements and Testing Approval. A person required to obtain a license to operate a laboratory that chooses to operate under a letter of exception — limited testing for rare diseases shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(1)">(1)</span> Submit:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(1)(a)">(a)</span> A completed:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(1)(a)(i)">(i)</span> Application as prescribed in <a class="internal-link " href="/us/md/exec/comar/10.10.03.04" title=".04 Letter of Exception and Permit — Administrative Procedures.">Regulation .04 of this chapter</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(1)(a)(ii)">(ii)</span> Report or questionnaire as required by the Secretary to determine regulatory compliance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(1)(b)">(b)</span> A copy of the laboratory's:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(1)(b)(i)">(i)</span> Current CLIA certificate issued by CMS; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(1)(b)(ii)">(ii)</span> Most recent CLIA survey report;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(1)(c)">(c)</span> Documentation of the rare disease testing offered or performed, including but not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(1)(c)(i)">(i)</span> The test procedure, including instructions for quality control and quality assurance;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(1)(c)(ii)">(ii)</span> A description of the disease or condition;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(1)(c)(iii)">(iii)</span> An explanation of the clinical validity of the test;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(1)(c)(iv)">(iv)</span> The performance characteristics of the test;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(1)(c)(v)">(v)</span> The expected turnaround time for patient test results; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(1)(c)(vi)">(vi)</span> Additional information necessary for determining eligibility and compliance with this subtitle; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(2)">(2)</span> Agree to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(2)(a)">(a)</span> Make records and reports available to the Department as the Secretary may require;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(2)(b)">(b)</span> Notify the Department when a change to a licensee's rare disease testing procedure occurs for the purpose of the Department's determining whether the change is in compliance with this subtitle;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(2)(c)">(c)</span> Perform not more than 50 rare disease tests each year on specimens from Maryland patients; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#A(2)(d)">(d)</span> Submit to the Department statistics that detail the number and types of rare disease tests performed each year on specimens from Maryland patients.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#B">B.</span> Standards. A person that wishes to obtain and maintain a letter of exception — limited testing for rare diseases shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#B(1)">(1)</span> Comply with good laboratory practices that include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#B(1)(a)">(a)</span> Following the manufacturer's instructions for instrument or test system operation and test performance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#B(1)(b)">(b)</span> Having and following a written procedure manual describing the processes for performing tests and reporting patient test results;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#B(1)(c)">(c)</span> Performing applicable instrument calibration procedures at least once every 6 months;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#B(1)(d)">(d)</span> Performing and documenting quality control procedures using applicable levels of control materials each day of testing; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#B(1)(e)">(e)</span> Performing and documenting that remedial action has been taken when problems or errors are identified; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#B(2)">(2)</span> Meet the requirements and standards in this subtitle applicable to a permitted laboratory including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#B(2)(a)">(a)</span> Proficiency testing under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.05" title="Chapter 05 Medical Laboratories — Proficiency Testing">COMAR 10.10.05</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#B(2)(b)">(b)</span> Quality assurance under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.06" title="Chapter 06 Medical Laboratories — Quality Assurance">COMAR 10.10.06</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#B(2)(c)">(c)</span> Personnel under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.07" title="Chapter 07 Medical Laboratories — Personnel">COMAR 10.10.07</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#B(2)(d)">(d)</span> Sanctions under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.08" title="Chapter 08 Medical Laboratories — Sanctions">COMAR 10.10.08</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#B(2)(e)">(e)</span> CLIA regulations incorporated by reference at <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.01.04#B(3)" title="">COMAR 10.10.01.04B(3)</a> — (5).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#C">C.</span> If the submitted application and explanatory documentation do not meet the requirements of this regulation or if the information submitted for the plan is insufficient to make a determination of compliance with this subtitle, a person may:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#C(1)">(1)</span> Submit amendments to the application and explanatory documentation; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#C(2)">(2)</span> Apply for a permit in accordance with this subtitle.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#D">D.</span> The OHCQ may conduct on-site surveys of a laboratory operating under a letter of exception — limited testing for rare diseases to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#D(1)">(1)</span> Investigate a complaint; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#D(2)">(2)</span> Determine compliance with this subtitle.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.10.03.06#E">E.</span> If a licensee wishes to perform more than 50 rare disease tests per year, the licensee shall submit an application for and obtain a permit as required under this subtitle.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.10.02" aria-label="Chapter 02 Medical Laboratories — General">
                <div class="h__ui">Previous</div>
                <span>Chapter 02 Medical Laboratories — General</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.10.04" aria-label="Chapter 04 Medical Laboratories">
                <div class="h__ui">Next</div>
                <span>Chapter 04 Medical Laboratories</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
